J&J Proposes $6.5B Deal To End Ovarian Cancer Claims

By Carolina Bolado · May 1, 2024, 11:36 AM EDT

Johnson & Johnson said Wednesday it is proposing a prepackaged reorganization plan for its talc unit that will pay out $6.5 billion to resolve claims that its talc-based baby powder caused ovarian...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login